Skip to main content
Fig. 3 | World Journal of Surgical Oncology

Fig. 3

From: lncRNA MALAT1 promotes HCC metastasis through the peripheral vascular infiltration via miRNA-613: a primary study using contrast ultrasound

Fig. 3

lncRNA MALAT1 expressed high and miRNA-613 expressed low in HCC metastatic patients. A lncRNA MALAT1 expression in HCC tissues and paracancer tissues of patients with HCC was detected by qRT-PCR, ***P < 0.001 vs paracancer, n = 120. B lncRNA MALAT1 expression in HCC tissues of HCC metastatic patients and HCC non-metastatic patients was detected by qRT-PCR, ***P < 0.001 vs HCC non-metastatic, n = 60. C CEUS grading and lncRNA MALAT1 in patients with HCC were analyzed through Pearson correlation analysis, n = 60. D miRNA-613 expression in HCC tissues and paracancer tissues of patients with HCC was detected by qRT-PCR, ***P < 0.001 vs paracancer, n = 120. E miRNA-613 expression in HCC tissues of HCC metastatic patients and HCC non-metastatic patients was detected by qRT-PCR was detected by qRT-PCR. F SPSS 24.0 software was used for ROC curve analysis of lncRNA MALAT1 and CEUS liver cancer diagnosis. G SPSS 24.0 software was used for ROC curve analysis on miRNA-613 and CEUS liver cancer diagnosis. ***P < 0.001 vs HCC non-metastatic, n = 60

Back to article page